Sepsis, January 2025 edition

This mechanistic preclinical study demonstrated that microbiota-derived tryptophan metabolites activate macrophage AhR, improving bacterial clearance and survival. The pathogen-derived siderophore enterobactin inhibited AhR activation and worsened sepsis, whereas tryptophan supplementation restored survival in mice.

Impact: The study establishes a causal microbiota–host–pathogen axis linking microbial metabolites, pathogen virulence, macrophage function, and sepsis survival. It identifies several translationally testable approaches, including AhR agonism, nutritional modulation, and siderophore neutralization.

Clinical Implications: The findings support future studies of AhR-directed therapies, microbiome-preserving antimicrobial stewardship, and metabolite-based interventions. Human pharmacology, safety, and the heterogeneity of microbiome composition must be addressed before clinical application.

This translational study developed E. coli cell-wall-derived carbon dots that competitively bind LBP/LPS, promote TLR4 degradation, suppress NF-κB and STING signaling, and reduce oxidative stress. The material improved survival and organ function in septic mice and cynomolgus monkeys and produced concordant anti-inflammatory effects in human PBMCs.

Impact: The study introduces an unconventional host-directed platform that converts pathogen-derived material into a multi-pathway immunomodulator. Cross-species validation, including nonhuman primates and human immune cells, substantially strengthens its translational potential.

Clinical Implications: The platform may become an adjunctive treatment for hyperinflammatory sepsis, but development requires rigorous evaluation of pharmacokinetics, immunogenicity, biodistribution, manufacturing consistency, and effects on antimicrobial host defense.

Single-cell RNA sequencing of patient-derived bronchoalveolar lavage fluid identified a neutrophil-dominated immunosuppressive program during sepsis. Five neutrophil subpopulations expanded during the immunosuppressive phase, highlighting cellular heterogeneity in the lung and potential targets for preventing secondary pulmonary infection.

Impact: The study provides high-resolution human evidence that pulmonary neutrophil heterogeneity is central to septic immunosuppression. It moves the field beyond total neutrophil counts toward state-specific immune monitoring and targeted intervention.

Clinical Implications: The findings may support future immune-monitoring panels and targeted strategies that preserve antimicrobial defense while limiting immunosuppressive neutrophil states. Clinical utility requires validation in larger cohorts and correlation with secondary infection and mortality outcomes.

This multinational study included 7,538 children across 19 countries and found that pediatric acute critical illness affected 13.1% of hospitalized children, rising to 28.0% in low-SDI countries. Sepsis or septic shock accounted for 10.4% of acute critical illness, and 59% of deaths occurred within 48 hours.

Impact: The study quantifies the global burden and timing of pediatric critical illness in resource-constrained settings. It identifies the first 48 hours as a high-yield window for strengthening triage, oxygenation, antibiotics, fluids, and basic organ support.

Clinical Implications: Health systems should prioritize early recognition and delivery of basic critical care, especially in low-resource hospitals. The results support implementation research focused on scalable interventions rather than dependence on high-cost technologies alone.

GroupFasterRisk is an interpretable machine-learning framework that generates sparse, clinician-friendly ICU mortality scores. It achieved performance comparable to APACHE IV/IVa while using substantially fewer variables and outperformed commonly used scores such as OASIS and SAPS II, offering a practical approach to transparent sepsis and critical-care prediction.

Impact: The framework addresses a major barrier to clinical AI adoption: the trade-off between predictive performance and interpretability. Its sparse and monotonic structure is suitable for auditing, bedside discussion, and integration into sepsis triage pathways.

Clinical Implications: Hospitals could use such models to support triage, escalation, and resource allocation while retaining clinician oversight. Before deployment, local recalibration, prospective impact assessment, fairness testing, and monitoring for model drift are required.